Title |
Exosomes: A Rising Star in Falling Hearts
|
---|---|
Published in |
Frontiers in Physiology, July 2017
|
DOI | 10.3389/fphys.2017.00494 |
Pubmed ID | |
Authors |
Jun-Yan Xu, Gui-Hao Chen, Yue-Jin Yang |
Abstract |
Although exosomes were previously recognized as a mechanism for discharging useless cellular components, growing evidence has elucidated their roles in conveying information between cells. They contribute to cell-cell communication by carrying nucleic acids, proteins and lipids that can, in turn, regulate behavior of the target cells. Recent research suggested that exosomes extensively participate in progression of diverse cardiovascular diseases (CVDs), such as myocardial infarction, cardiomyopathy, pulmonary arterial hypertension and others. Here, we summarize effects of exosome-derived molecules (mainly microRNAs and proteins) on cardiac function, to examine their potential applications as biomarkers or therapeutics in CVDs. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 3 | 27% |
United Kingdom | 1 | 9% |
Germany | 1 | 9% |
Austria | 1 | 9% |
New Zealand | 1 | 9% |
Canada | 1 | 9% |
Switzerland | 1 | 9% |
Unknown | 2 | 18% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 8 | 73% |
Scientists | 2 | 18% |
Practitioners (doctors, other healthcare professionals) | 1 | 9% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 119 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 21 | 18% |
Student > Bachelor | 17 | 14% |
Researcher | 15 | 13% |
Student > Master | 11 | 9% |
Student > Doctoral Student | 10 | 8% |
Other | 19 | 16% |
Unknown | 26 | 22% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 28 | 24% |
Biochemistry, Genetics and Molecular Biology | 26 | 22% |
Agricultural and Biological Sciences | 16 | 13% |
Engineering | 7 | 6% |
Pharmacology, Toxicology and Pharmaceutical Science | 6 | 5% |
Other | 11 | 9% |
Unknown | 25 | 21% |